Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Emmanuel Guardiola"'
Autor:
Frédérique Penault-Llorca, Fabrice Kwiatkowski, Antoine Arnaud, Christelle Levy, Marianne Leheurteur, Lionel Uwer, Olfa Derbel, Annick Le Rol, Jean-Philippe Jacquin, Christelle Jouannaud, Nathalie Quenel-Tueux, Véronique Girre, Cyril Foa, Emmanuel Guardiola, Alain Lortholary, Stéphanie Catala, Séverine Guiu, Alexander Valent, Diane Boinon, Jérome Lemonnier, Suzette Delaloge
Publikováno v:
Breast, Vol 49, Iss , Pp 132-140 (2020)
Purpose: Genomic tests can identify ER-positive HER2-negative localized breast cancer patients who may not benefit from adjuvant chemotherapy. Such tests seem especially interesting in “intermediate” clinico-pathological risk categories. The psyc
Externí odkaz:
https://doaj.org/article/d70246acf83c4620ae1e76cf9395b7f1
Publikováno v:
Multimodal Technologies and Interaction, Vol 5, Iss 11, p 70 (2021)
Digital entertainment games frequently address current societal issues that are also dealt with in geography education, such as climate change or sustainable city development, and give various opportunities for learning. However, in order to be fully
Externí odkaz:
https://doaj.org/article/c18bf32d68c04881b4ae7abc46bc756e
Publikováno v:
Journal of Gaming & Virtual Worlds. 14:3-6
This introduction opens a Special Issue devoted to Cyberpunk 2077 (2020), an open-world, action‐adventure roleplaying video game whose release has polarized players and critics alike for a number of reasons ranging from its technically problematic
Antura and the Letters was chosen by EduAppSyria as innovative digital game solution to promote literacy and psychosocial well-being in refugee children. This article reports the international assessment of its effectiveness in the Azraq Camp in Jord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb3ce1fce80c7e364ea030f014bba81a
https://doi.org/10.31219/osf.io/7u946
https://doi.org/10.31219/osf.io/7u946
Autor:
Emmanuelle Samalin, Hélène Senellart, Ludovic Evesque, Olivier Bouché, Faiza Khemissa, Christelle De La Fouchardiere, Anthony Lopez, Slimane Dermeche, Damien Botsen, David Tougeron, Aziz Zaanan, Meher BEN Abdelghani, Emmanuel Guardiola, Olivier Dubreuil, Valérie Le Brun Ly, Audrey Hennequin, Nicolas De Sousa Carvalho, Florence Castan, Anthony Turpin
Publikováno v:
Journal of Clinical Oncology. 41:387-387
387 Background: Several options have been evaluated as 2nd line treatment in mGA after failure of 1st line platinum based chemotherapy including taxanes and IRI as monotherapies or paclitaxel combined with ramucirumab but with a limited efficacy. REG
Designers of digital entertainment games and designers of games for education can learn from each other when it comes to gameplay mechanics, content and mediation techniques that enable a fun and at the same time educational experience for players. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b45783a3d4d85955d9e27687e6e3ea
https://doi.org/10.31235/osf.io/9fq4u
https://doi.org/10.31235/osf.io/9fq4u
Autor:
Giovanni Scambia, Daniela Sambataro, Coraline Dubot, Rossella Lauria, Francesco Raspagliesi, Patricia Pautier, Simona Frezzini, S Mammoliti, U De Giorgi, Ugo De Giorgi, C Sessa, Angiolo Gadducci, Isabelle Ray-Coquard, A Gadducci, Rémy Largillier, Francesco Perrone, Alessandra Bologna, Sandro Pignata, G Scambia, Elena Zafarana, E Breda, Florence Joly, R Largillier, Saverio Cinieri, C Pisano, Carmela Pisano, C Gallo, Frédéric Selle, Vanda Salutari, Cristiana Sessa, Aristotelis Bamias, F Joly, R Lauria, A Ardizzoia, Laure Favier, Nicoletta Colombo, D Sambataro, F Perrone, Domenica Lorusso, C Dubot, G Daniele, Emmanuel Guardiola, A Bamias, Gennaro Daniele, V Salutari, F Selle, S. Mammoliti, E Zafarana, P Pautier, M Orditura, Enrico Breda, A Bologna, E Guardiola, Michele Orditura, Ciro Gallo, L Favier, S Cinieri, N Colombo, I Ray-Coquard, S Frezzini, S Pignata, F Raspagliesi, Antonio Ardizzoia
Background: Bevacizumab is approved in combination with chemotherapy for the treatment of ovarian cancer, either in first-line therapy or for patients with recurrent disease not previously treated with the same drug. We aimed to test the value of con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5cf8324eaa8e8e6577f2c091ed2f66
http://hdl.handle.net/11591/461646
http://hdl.handle.net/11591/461646
Autor:
Jacobus Pfisterer, Catherine M Shannon, Klaus Baumann, Joern Rau, Philipp Harter, Florence Joly, Jalid Sehouli, Ulrich Canzler, Barbara Schmalfeldt, Andrew P Dean, Alexander Hein, Alain G Zeimet, Lars C Hanker, Thierry Petit, Frederik Marmé, Ahmed El-Balat, Rosalind Glasspool, Nikolaus de Gregorio, Sven Mahner, Tarek M Meniawy, Tjoung-Won Park-Simon, Marie-Ange Mouret-Reynier, Cristina Costan, Werner Meier, Alexander Reinthaller, Jeffrey C Goh, Tifenn L'Haridon, Sally Baron Hay, Stefan Kommoss, Andreas du Bois, Jean-Emmanuel Kurtz, Sven Ackermann, Christoph Anthuber, Mustafa Aydogdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, Ricardo Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Grafe, Martin Griesshammer, Eva-Maria Grischke, Isolde Gröll, Martina Gropp-Meier, Dietrich Hager, Volker Hanf, Carla Verena Hannig, Peer Hantschmann, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, Thomas Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon-Dschun Ko, Hans-Joachim Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, Peter Ledwon, Sabine Lemster, Benno Lex, Clemens Liebrich, Ralf Lorenz, Hans-Joachim Lück, Peter Mallmann, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober, Gülten Oskay-Özcelik, Horst Ostertag, Martin Pölcher, Beate Rautenberg, Daniel Rein, Wilhelm Reiter, Andreas Rempen, Ingo Runnebaum, Marcus Schmidt, Sabine Schnohr, Heinz Scholz, Willibald Schröder, Eike Simon, Antje Sperfeld, Annette Steckkönig, Hans-Georg Strauß, Ronaldo Stuth, Jürgen Terhaag, Falk Thiel, Marc Thill, Oliver Tomé, Christoph Uleer, Susanne Vogel, Hermann Voß, Michael Weigel, Ulrich Winkler, Arthur Wischnik, Tobias Zeiser, Andreas Zorr, Ros Glasspool, Emma Hudson, Rachel Jones, Judith Lafleur, Christian Marth, Edgar Petru, Yoland Antill, Mary Azer, Sally Baron-Hay, Philip Beale, Stephen Begbie, Allison Black, Karen Briscoe, Andrew Dean, Jeffrey Goh, Sandra Harvey, Chee Lee, Marco Matos, Tarek Meniawy, Inger Olesen, Catherine Shannon, Paul Vasey, Sophie Abadie-Lacourtoisie, Olivier Arsene, Sophie Barthier, Célia Becuwe-Roemer, Dominique Berton-Rigaud, Maria Cappiello-Bataller, Stéphanie Catala, Francesco Del Piano, Gaël Deplanque, Raymond Despax, Nadine Dohollou, Claire Garnier-Tixidré, Julien Grenier, Emmanuel Guardiola, Anne-Claire Hardy-Bessard, Claudia Lefeuvre-Plesse, Marianne Leheurteur, Anne Lesoin, Charles-Briac Levache, Raffaele Longo, Alain Lortholary, Jérôme Meunier, Nadia Raban, Olivier Romano, Jean-Michel Vannetzel, Alain Zannetti
Publikováno v:
Lancet Oncology
Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
The Lancet Oncology
The Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
The Lancet Oncology
The Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
Background:\ud State-of-the art therapy for recurrent ovarian cancer suitable for platinum-based re-treatment includes bevacizumab-containing combinations (eg, bevacizumab combined with carboplatin–paclitaxel or carboplatin–gemcitabine) or the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6dcdfeb9666bdc098f5e231578e0974
https://hal.science/hal-02887894
https://hal.science/hal-02887894
Autor:
N Quenel-Tueux, Séverine Guiu, Fabrice Kwiatkowski, Cyril Foa, Jean-Philippe Jacquin, Veronique Girre, Olfa Derbel, Suzette Delaloge, Alain Lortholary, Marianne Leheurteur, Annick Le Rol, Antoine Arnaud, Emmanuel Guardiola, Christelle Jouannaud, Christelle Levy, Alexander Valent, Frédérique Penault-Llorca, Lionel Uwer, Diane Boinon, Jérôme Lemonnier, Stéphanie Catala
Publikováno v:
The Breast
The Breast, 2020, 49, pp.132-140. ⟨10.1016/j.breast.2019.10.013⟩
Breast, Vol 49, Iss, Pp 132-140 (2020)
The Breast : official journal of the European Society of Mastology
The Breast, 2020, 49, pp.132-140. ⟨10.1016/j.breast.2019.10.013⟩
Breast, Vol 49, Iss, Pp 132-140 (2020)
The Breast : official journal of the European Society of Mastology
Purpose Genomic tests can identify ER-positive HER2-negative localized breast cancer patients who may not benefit from adjuvant chemotherapy. Such tests seem especially interesting in “intermediate” clinico-pathological risk categories. The psych
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab4f2105e1be32ed3282f95fbca33b8
https://hal.archives-ouvertes.fr/hal-03049894
https://hal.archives-ouvertes.fr/hal-03049894
Autor:
Emmanuel Guardiola, André Czauderna
Publikováno v:
Electronic Journal of e-Learning. 17
The field of game design for educational content lacks a focus on methodologies that merge gameplay and learning. Existing methodologies typically fall short in three ways: they neglect the unfolding of gameplay through players’ actions over a shor